Propanc Biopharma reported earnings of -$ 12.22 per PPCB share on Nov 13, 2026,Meanwhile, the company posted an EPS of -$ 84.63 during the same period last year, marking a
| Report Date | Nov 13, 2026 |
|---|---|
| Earnings Per Share (Surprise) | -$ 12.22 |
| Last Year's EPS | -$ 84.63 |
| EPS YoY Change |
Out of the last 43 earnings reporting periods, Propanc Biopharma beat analysts’ expectations 0 times and fell short of expectations 0 time(s). Propanc Biopharma reported earnings per share of -$ 12.22 in the last report.
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | - | -$ 12.22 | -$ 7.50 | |
| Oct 5, 2026 | - | -$ 40.70 | -$ 9.75 | |
| Sep 25, 2026 | - | -$ 1.38 | -$ 8.75 | |
| May 14, 2026 | - | -$ 7.00 | -$ 312.50 | |
| Feb 17, 2026 | - | -$ 7.50 | -$ 805.75 | |
| Nov 14, 2025 | - | -$ 9.75 | -$ 7,195.50 | |
| Sep 29, 2025 | - | -$ 8.75 | -$ 2,398.75 | |
| May 15, 2025 | - | -$ 312.50 | -$ 15,625 | |
| Feb 14, 2025 | - | -$ 805.75 | -$ 46,875 | |
| Nov 14, 2024 | - | -$ 7,195.50 | -$ 62,500 | |
| Sep 30, 2024 | - | -$ 2,398.75 | -$ 3.25 | |
| May 15, 2024 | - | -$ 15,625 | -$ 10.50 | |
| Feb 20, 2024 | - | -$ 46,875 | -$ 13.25 | |
| Nov 14, 2023 | - | -$ 62,500 | -$ 53.25 | |
| Sep 28, 2023 | - | -$ 3.25 | -$ 131.50 | |
| May 15, 2023 | - | -$ 10.50 | -$ 15.63M | |
| Feb 9, 2023 | - | -$ 13.25 | -$ 31.25M | |
| Nov 14, 2022 | - | -$ 53.25 | -$ 31.25M | |
| Sep 28, 2022 | - | -$ 131.50 | -$ 2,082.50 | |
| May 16, 2022 | - | -$ 15.63M | -$ 187.50M |
Propanc Biopharma’s stock was trading at $ 1.92 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 12.22 | $ 1.92 | ||
| Oct 5, 2026 | -$ 40.70 | $ 0.5075 | $ 0.4913 | |
| Sep 25, 2026 | -$ 1.38 | $ 0.6018 | $ 0.5334 | |
| May 14, 2026 | -$ 7.00 | $ 2.33 | $ 1.70 | |
| Feb 17, 2026 | -$ 7.50 | $ 5.33 | $ 5.25 | |
| Nov 14, 2025 | -$ 9.75 | $ 19.55 | $ 18.90 | |
| Sep 29, 2025 | -$ 8.75 | $ 45.50 | $ 42.50 | |
| May 15, 2025 | -$ 312.50 | $ 70.00 | $ 73.25 | |
| Feb 14, 2025 | -$ 805.75 | $ 69.00 | $ 222.25 | |
| Nov 14, 2024 | -$ 7,195.50 | $ 600.00 | $ 450.00 | |
| Sep 30, 2024 | -$ 2,398.75 | $ 450.00 | $ 412.50 | |
| May 15, 2024 | -$ 15,625 | $ 1,350.00 | $ 1,050.00 | |
| Feb 20, 2024 | -$ 46,875 | $ 6,600.00 | $ 5,400.00 | |
| Nov 14, 2023 | -$ 62,500 | $ 16,350 | $ 19,950 | |
| Sep 28, 2023 | -$ 3.25 | $ 37,163 | $ 1.22 | |
| May 15, 2023 | -$ 10.50 | $ 10.00 | $ 10.00 | |
| Feb 9, 2023 | -$ 13.25 | $ 20.00 | $ 20.00 | |
| Nov 14, 2022 | -$ 53.25 | $ 55.00 | $ 40.00 | |
| Sep 28, 2022 | -$ 131.50 | $ 75.00 | $ 65.00 | |
| May 16, 2022 | -$ 15.63M | $ 410.00 | $ 400.00 |
Propanc Biopharma released its most recent earnings reports in November 2026, October 2026, September 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
